High blood phosphorus concentration triggers various complications caused by phosphorous interaction with blood calcium or parathyroid hormones
, and makes patients more prone to calcium deposition in soft tissues such as the coronary arteries, increasing the risk of ischemic heart disease.
Anabolic agents such as parathyroid hormones (PTHs) capable of increasing bone mineral density (BMD), restoring skeletal structure, and curtailing fracture risk hold an edge over traditional antiresorptive therapies.
Keywords in this release: osteoporosis therapies, osteopenia, osteoporosis bisphosphonates, calcitonins, Fosamax, Actonel, Boniva, Zometa, selective estrogen receptor modulators, SERMs, chemotherapy-induced menopause, anabolic agents, parathyroid hormones, PTHs, bone mineral density, BMD, antiresorptive therapies, Eli Lilly, Forteo, Medicare reforms, research, information, market, trends, technology, service, forecast, market share.
Protein Delivery's leading drugs in development include oral insulin for the treatment of diabetes, oral calcitonin and parathyroid hormones
for treating osteoporosis, and several drugs targeted to the brain for central nervous system disorders.